High ambient glucose levels modulates the production of MMP-9 and α5(IV) collagen by cultured podocytes

被引:58
作者
Bai, YL [1 ]
Wang, LZ [1 ]
Li, YQ [1 ]
Liu, SY [1 ]
Li, JZ [1 ]
Wang, HY [1 ]
Huang, HC [1 ]
机构
[1] Peking Univ, Hosp 1, Div Nephrol, Beijing 100034, Peoples R China
关键词
diabetic nephropathy; glomerular epithelial cells; glomerulosclerosis; extracellular matrix; glomerular filtration barrier;
D O I
10.1159/000091464
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Recent evidences have demonstrated an important role for glomerular visceral epithelial cell ( podocyte) in the development and progression of diabetic nephropathy. We investigated the high-glucose (HG)-triggered signaling pathway and its role in matrix metalloproteinase (MMP) production in murine podocytes. The activity of 92-kDa (MMP-9) gelatinase, but not of 72 kDa (MMP-2), in an HG medium significantly increased during incubation of 2 to 3 days and decreased during incubation of more than 5 days revealed by Gelatin zymography. Opposite to the increases in MMP-9 activity, HG medium produced significant decreases in the protein levels of alpha 5(IV) collagen. Changes in MMP-9 activity were associated with the same pattern as MMP-9 mRNA levels in podocytes exposed to HG media. HG medium rapidly activated ERK1/2 MAPK in podocytes. Moreover, ERK1/2 activation was required for HG-induced enhancement of MMP-9 activity and a decrease in the level of a5( IV) collagen. HG incubation rapidly induced an increase in the nuclear accumulation of Ets-1 protein. Blocking the ERK pathway suppressed HG-induced expression and nuclear accumulation of transcriptional factor Ets-1, and MMP-9 mRNA expression. We suggest that short-or long-term exposure to HG concentrations increases or decreases MMP-9 production and alpha 5(IV) collagen expression in podocytes, this may contribute to the GBM abnormality caused by an imbalance in extracellular matrix (ECM) synthesis and degradation, and may play a critical role in the pathogenesis of proteinuria in diabetic nephropathy. Copyright (c) 2006 S. Karger AG, Basel.
引用
收藏
页码:57 / 68
页数:12
相关论文
共 42 条
[1]  
Artishevsky A, 1997, J AM SOC NEPHROL, V8, P61
[2]   Selective modulation of the secretion of proteinases and their inhibitors by growth factors in cultured differentiated podocytes [J].
Asanuma, K ;
Shirato, I ;
Ishidoh, K ;
Kominami, E ;
Tomino, Y .
KIDNEY INTERNATIONAL, 2002, 62 (03) :822-831
[3]   PROTEOLYTIC-ENZYMES AS MEDIATORS OF GLOMERULAR INJURY [J].
BARICOS, WH ;
SHAH, SV .
KIDNEY INTERNATIONAL, 1991, 40 (02) :161-173
[4]   Diabetes and nephropathy [J].
Caramori, ML ;
Mauer, M .
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2003, 12 (03) :273-282
[5]   Mitogen-activated protein kinases mediate matrix metalloproteinase-9 expression in vascular smooth muscle cells [J].
Cho, A ;
Graves, J ;
Reidy, MA .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (12) :2527-2532
[6]   Elevated matrix metalloproteinase-2 and-9 in urine, but not in serum, are markers of Type 1 diabetic nephropathy [J].
Diamant, M ;
Hanemaaijer, R ;
Verheijen, JH ;
Smit, JWA ;
Radder, JK ;
Lemkes, HHPJ .
DIABETIC MEDICINE, 2001, 18 (05) :423-424
[7]   Glucocorticoid-mediated suppression of cytokine-induced matrix metalloproteinase-9 expression in rat mesangial cells:: Involvement of nuclear factor-κB and Ets transcription factors [J].
Eberhardt, W ;
Schulze, M ;
Engels, C ;
Klasmeier, E ;
Pfeilschifter, J .
MOLECULAR ENDOCRINOLOGY, 2002, 16 (08) :1752-1766
[8]   Increased plasma metalloproteinase-9 concentrations precede development of microalbuminuria in non-insulin-dependent diabetes mellitus [J].
Ebihara, I ;
Nakamura, T ;
Shimada, N ;
Koide, H .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 32 (04) :544-550
[9]   Comparison of renal morphology in the Streptozotocin and the SHR/N-cp models of diabetes [J].
Gross, ML ;
Ritz, E ;
Schoof, A ;
Adamczak, M ;
Koch, A ;
Tulp, O ;
Parkman, A ;
El-Shakmak, A ;
Szabo, A ;
Amann, K .
LABORATORY INVESTIGATION, 2004, 84 (04) :452-464
[10]   ACE-inhibitors but not endothelin receptor blockers prevent podocyte loss in early diabetic nephropathy [J].
Gross, ML ;
El-Shakmak, A ;
Szábó, A ;
Koch, A ;
Kuhlmann, A ;
Münter, K ;
Ritz, E ;
Amann, K .
DIABETOLOGIA, 2003, 46 (06) :856-868